On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

In this issue

Home Eurosurveillance Edition  2015: Volume 20/ Issue 10 Article 3
Back to Table of Contents
Previous Download (pdf)

Eurosurveillance, Volume 20, Issue 10, 12 March 2015
Research articles
Household transmissibility of avian influenza A (H7N9) virus, China, February to May 2013 and October 2013 to March 2014
  1. Department of Biostatistics and Emerging Pathogens Institute, University of Florida, Gainesville, Florida, United States
  2. Public Health Emergency Center, Chinese Center for Disease Prevention and Control, Beijing, China
  3. State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China
  4. Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
  5. Department of Environmental and Global Health, University of Florida, Gainesville, Florida, United States
  6. Department of Mathematics, Stockholm University, Stockholm, Sweden
  7. Provincial Center for Disease Prevention and Control, Hangzhou, Zhejiang, China
  8. Municipal Center for Disease Prevention and Control, Shanghai, China
  9. Provincial Center for Disease Prevention and Control, Nanjing, Jiangsu, China

Citation style for this article: Yang Y, Zhang Y, Fang L, Halloran ME, Ma M, Liang S, Kenah E, Britton T, Chen E, Hu J, Tang F, Cao W, Feng Z, Longini Jr IM. Household transmissibility of avian influenza A (H7N9) virus, China, February to May 2013 and October 2013 to March 2014. Euro Surveill. 2015;20(10):pii=21056. Article DOI:
Date of submission: 19 August 2014

To study human-to-human transmissibility of the avian influenza A (H7N9) virus in China, household contact information was collected for 125 index cases during the spring wave (February to May 2013), and for 187 index cases during the winter wave (October 2013 to March 2014). Using a statistical model, we found evidence for human-to-human transmission, but such transmission is not sustainable. Under plausible assumptions about the natural history of disease and the relative transmission frequencies in settings other than household, we estimate the household secondary attack rate (SAR) among humans to be 1.4% (95% CI: 0.8 to 2.3), and the basic reproductive number R0 to be 0.08 (95% CI: 0.05 to 0.13). The estimates range from 1.3% to 2.2% for SAR and from 0.07 to 0.12 for R0 with reasonable changes in the assumptions. There was no significant change in the human-to-human transmissibility of the virus between the two waves, although a minor increase was observed in the winter wave. No sex or age difference in the risk of infection from a human source was found. Human-to-human transmissibility of H7N9 continues to be limited, but it needs to be closely monitored for potential increase via genetic reassortment or mutation.


Influenza A (H7N9) was first detected among humans in eastern China in February 2013 and, as of 7 December 2014, had caused 453 laboratory-confirmed clinical human infections with 178 deaths in China, according to the Chinese Center for Disease Control and Prevention (Chinese CDC). The virus is a reassortant of avian H7, N9 and H9N2 strains [1] with evidence of the capacity to bind to mammalian cells [2,3] and limited airborne transmission in animal models [4,5]. Currently, the virus is not pathogenic in birds, but highly pathogenic and virulent in humans [6-9]. Normally, the influenza season in humans in the northern hemisphere runs from October to April with some variation in timing [10,11]. After a relative hiatus in the number of human H7N9 cases over the summer of 2013 in China (e.g. only two cases reported in July 2013), a second large wave of cases appeared, starting in October 2013 [12].

While the ongoing sporadic reporting of cases (per communication with the Chinese CDC) implies the H7N9 virus has not yet reached the stage of efficient human-to-human transmission, an animal model has shown another H7 virus was able to transmit among co-housed ferrets without much loss of virulence, with a few mutations obtained after 10 serial passages [13]. It is therefore highly relevant to assess the risks of human-to-human transmission using available data.

The household is a setting well suited to investigating human-to-human transmission of many infectious agents, including influenza viruses [14]. So far, no quantitative analysis of household transmission of H7N9 virus has been reported, though qualitative epidemiological descriptions of possible transmissions in a few families with more than one laboratory-confirmed case have been presented [15-18]. We use household information on laboratory-confirmed cases collected by the Chinese CDC to estimate the household secondary attack rate (SAR), i.e. the probability that a typical index case infects a given household member. In addition, the basic reproductive number, R0, defined as the number of people a typical infected person would infect in a completely susceptible population, is estimated from the SAR in conjunction with assumptions about the contribution of schools and the general community relative to households in future epidemics. Other investigators estimated R0 to be 0.10 using the sequence of reported cases during the spring outbreak of 2013 [19]. We provide the first rigorous evaluation of R0 based on transmissibility in the household setting.


Household study
Contact data were collected by the Chinese CDC on households with laboratory-confirmed symptomatic cases over the two distinct waves of the epidemic, 125 households during the first wave in the spring of 2013, and another 187 households from the second wave in the winter and spring of 2013–14, offering a unique opportunity to examine the potential change in human-to-human transmissibility of the virus. This investigation was part of the public health emergency response of Chinese CDC, and therefore no informed consent of the household members was required.
A household in this study was defined as a group of related family members living in the same building structure and in daily close contact with each other (our definition of close contact is given below). The case definitions for clinical and confirmed human infections with H7N9 were similar to the H5N1 case definitions suggested by the World Health Organization in 2006. Data of both laboratory-confirmed clinical cases and their close contacts, including household members, were obtained from a review of medical records and interviews with relatives, contacts and health-care providers. Close contacts of a confirmed case were monitored for seven days for symptoms, and throat swabs were collected from contacts with respiratory symptoms for laboratory testing. Throat swabs were also collected from some close contacts without symptoms. Details of the case definition, laboratory methods and data collection were described previously [18].

Households of laboratory-confirmed clinical cases from all 10 provinces (Shanghai, Zhejiang, Jiangsu, Anhui, Jiangxi, Shandong, Beijing, Henan, Hunan and Fujian) affected by the first wave were included. Households from three provinces (Zhejiang, Hunan and Guangdong) affected by the second wave during October 2013 to March, 2014, were added. Age, sex and dates of symptom onset, hospitalisation, death and recovery (if known) were collected for all family members. In addition, the following types of contact with the index case were recorded for each family member: (i) dining together; (ii) living in the same housing unit; (iii) sharing utensils, towels, toys, etc.; (iv) having contact with excreta (excrement and urine) of cases; (v) providing care; (vi) visiting; and (vii) other contacts. We define close contact as all contact types except for (vi) and (vii). Non-close contacts were excluded from our analysis.

Natural history of avian influenza A(H7N9) in human cases
There is limited information on the natural history of infection in humans caused by the H7N9 virus, as the exposure dates cannot be clearly identified for most cases. However, to estimate transmission probabilities, distributional assumptions often have to be made about the natural history, in particular the distributions of the incubation period (i.e. time from infection to the onset of influenza symptoms), the latent period (i.e. time from infection to the onset of infectiousness) and the infectious period (i.e. time that an infected person is infectious to others). However, there are little data about these periods.

Incubation and latent periods
Cowling et al. estimated the mean incubation period of H7N9 to be 3.1 days [6]. Chen et al. reported a 3-, 6- and 8-day lag between last exposure to live poultry and symptom onset in three patients, an average of 5.8 days [20]. Huang et al. found even longer incubation periods, a median of six days (range: 2–10) among 10 patients with a single self-reported exposure day and 7.5 days among 12 patients with multiple self-reported exposure days [21]. In contrast, former results about historical seasonal influenza suggested average incubation periods of those viruses of around two to three days [22].

We consider three possible distributions for our analysis (upper panel of Table 1). For the primary analysis, we adopt a minimum (dmin) of two days and a maximum (dmax) of eight days, with a probability mass distribution of For influenza, the latent period and the incubation period are similar [23], and we assume the two periods overlap.

Table 1. Assumptions about probability distributions for the incubation period and relative infectiousness since symptom onset (day 1) for the infectious period for avian influenza A(H7N9) in human cases

Infectious period
While the average time from symptom onset to recovery could be as long as 15 days (based on the surveillance data provided by the Chinese CDC), the actual duration of the infectious period is likely to be much shorter. For seasonal influenza, symptoms usually resolve in a week, and previous studies on seasonal and pandemic influenza A (H1N1) suggested a likely range of 7–10 days after symptom onset for the viral load to become undetectable [24-26]. Information on pathological and immunological response regarding the avian H7N9 is scarce. In a study of mice infected with H7N9 virus isolated from humans and ducks, viral titres were not detectable after day 8 post infection [27].

We explore three settings for the infectious period, each setting given by a fixed duration with decaying relative infectivity (lower panel of Table 1). We assume the infectious period starts from the day of symptom onset (day 1). The medium setting is adopted for the primary analysis, i.e. the duration of the infectious period is D = 10 days, and the relative infectivity levels are η=(η1,⋯,η10 )=(1,1,1,1,0.9,0.8,0.7,0.5,0.3,0.1). This setting gives a mean serial interval of approximately 9.4 days, slightly longer than the crude estimate of 7.5 days (see Results).

Human-to-human transmissibility
A likelihood-based statistical transmission model is used to test the hypothesis of no human-to-human transmission and to estimate the SAR and R0 [22,28]. Suppose we observe an epidemic from day 1 to day T among a population of N individuals in H households. Person-to-person transmissibility of the virus is measured by the probability that an infectious person infects his or her susceptible household contact in one day, denoted by p. The transmission probability can be adjusted for covariates via a logistic regression model given by logit( pijt )=logit(p)+X'ijtβ, where Xijt is the vector of covariates associated with an infectious person j and a susceptible person i on day t. We let β be the vector of coefficients, where eβ is interpreted as the odds ratios. To account for exposure to an environmental reservoir such as poultry and to unknown casual contacts with human sources outside of the household, we assume that a susceptible person is infected by external sources during one day with probability b. Suppose that we have observed households ascertained by index cases. Let h(i) be the collection of members of the household of individual i, and let be the symptom onset day of individual i. Then, the probability that susceptible individual i escapes infection during day t is

Where η(k) is the relative infectiousness of day k of the infectious period. We define h(i) to be the collection of observed symptom onset days of all members in the household of individual i. Let θ(k) be the probability that the incubation period is k days. The likelihood contribution of individual i is

We embed the same likelihood structure in a resampling-based approach to test the null hypothesis H0: p = 0   [29].

The SAR over an infectious period of D days is

The SAR specific to a covariate value X is given by replacing p with logit−1 [logit(p) + X' β]. To estimate R0, the fact that the probability of becoming an index case differs across age groups has to be considered, as it is known that older people have a higher chance of visiting high-risk areas such as live poultry markets [6,30]. For a population partitioned into three age groups: 0–19, 20–59 and ≥ 60 years, the basic reproductive number is given by

Where πj is the probability that an index case belongs to age group j, nj the average household size if the index case is from age group j, and ρS and ρC are the relative contact frequencies of an infectious person in school and the community compared with within household, respectively. The community refers to all places other than households and schools where transmission occurs. Lacking the data to determine the ρS and ρC specific to China, we use the information in a previous study of influenza A(H1N1)pdm09 in the United States [22], where the plausible ranges for the local reproductive numbers in households (RH) and schools (RS) were 0.6–0.9 and 2.0–2.5, respectively, and the corresponding range for ρS =RS/RH  was 2–4, which is used in our analysis. Another previous study of influenza pandemics in the United States showed that the community at large generally accounts for somewhat fewer transmissions of influenza virus than within households [14]. The values 0, 0.5 and 1.0 were used for ρC in the A(H1N1)pdm09 study [22]. In our analysis for H7N9, we use 0.5, 1.0 and 1.5 for ρC to reflect the higher population density in public places in China.

We estimate πj using a conditional Poisson model, in which temporal and spatial heterogeneity are controlled for by aggregating the data by appropriate location and time, e.g. by prefecture and week. Let Yktj be the number of cases in age group j in prefecture k with symptom onset during week t. We assume Yktj~Poisson(λktj)  with the intensity λktj=Nkj eγkt+βj, where Nkj is the population size in age group j of prefecture k, and exp(γkt) is the rate of a single person in the reference age group of prefecture k becoming a case during week t. For the parameters to be identifiable, we set β3 = 0, i.e., setting the age group ≥ 60 years as the reference group. Conditioning on the total number of cases Ykt=∑jYktj , the vector (Ykt1, Ykt2, Ykt3) follows a multinomial distribution with size Ykt and probabilities 

The maximum likelihood estimates of β1 and β2, denoted by  and  , are found by maximising the log-likelihood 

A reasonable estimate for πj is 

where Nj=kNkj and . Due to data availability, we used surveillance data up to 27 January 2014 to estimate πj.


We collected household data for 130 laboratory-confirmed clinical cases in 125 households in 10 provinces for February to May 2013 and for 196 laboratory-confirmed clinical cases in 187 households in Hunan, Zhejiang and Guangdong provinces for October 2013 to March 2014. The epidemic curves of the cases in these households during the two waves are shown in Figure 1 (panels A and B). Interestingly, multi-case households appeared from the very beginning of the 2013 wave. After excluding households without close contacts, 118 cases in 113 households in the first wave and 190 cases in 181 households in the second were used in this analysis. There was an asymptomatic infection identified in one household in the first wave, but this person was considered a non-case in our analysis; i.e., we only focus on laboratory-confirmed infections with clinical symptoms, because (i) it is not clear whether asymptomatic hosts can transmit the virus or not, and (ii) probably not all asymptomatic infections were detected.

Figure 1. Laboratory-confirmed avian influenza A(H7N9) cases in humans from (A) February–May 2013 (125 households, 130 cases) and (B) October 2013–March 2014 (187 households, 196 cases), household data, China

Under the assumption that all non-index cases were infected by the index cases, an estimate of the mean serial interval is 7.5 days (95% confidence interval (CI): 4.9 to 9.0). There was no difference in the distribution of the serial interval between the two waves (p value = 0.31 based on the two-sample Wilcoxon test). Using the transmission model, we first test the hypothesis of no human-to-human transmission, and we then estimate the SAR and R0 without adjusting for any covariate (Table 2). The estimation of R0 is based on the estimates of  and  obtained from the conditional Poisson model. In addition to taking into account the uncertainty in the natural history of disease, the results are also stratified by the relative contact frequency between a case and his or her household members within a hospital compared with within the household, denoted by α. When α is assumed unknown, its estimate varies dramatically from well below one to well above one, depending on the assumption about the natural history of disease. This indicates a lack of information about α in the data. Consequently, we assume α is known and examine results at three levels of α: 1.0, 0.5 and 0.1, based on the rationale that a family member was more likely to be cautious in having contact with an infected person who was hospitalised. Hypothesis testing is performed only under α = 1. The statistical evidence for human-to-human transmission is significant for most plausible distributions of the incubation and infectious periods except when both of them are short or both are long. The daily probability of infection by external sources, b, is estimable only under the setting of both the incubation and infectious periods being short. In all other settings, the maximum likelihood estimate (MLE) of b is given by the boundary value 0. As a result, we set b = 0 for estimating SAR and R0 in the primary analysis. Given α = 1, regardless of the assumption of the natural history, the estimates for SAR and R0 are generally low and stable. Using median incubation and infectious periods as the primary setting, we estimate SAR as 1.4% (95% CI: 0.8 to 2.3) and R0 as 0.08 (95% CI: 0.05 to 0.13), respectively, i.e. the probability that an H7N9 case infects another household contact is 0.014, and an H7N9 case infects an average of 0.08 other people. Lower values of α correspond to slightly higher estimates for SAR and R0, and the estimates appear higher with longer infectious periods but are insensitive to the incubation period. With α = 0.1 and a long infectious period, the estimates reach 2.2% for SAR and 0.12 for R0. The interpretation of the estimates for SAR and R0 under α < 1 is limited to the household setting, i.e. as if the infected person will not be hospitalised.

Table 2. Estimates of secondary attack rate and basic reproductive number based on household clusters of avian influenza A(H7N9) cases in humans, ignoring poultry-to-human transmission, China, February–May 2013 (113 households, 118 cases) and October 2013–March 2014 (181 households, 190 cases) 

The above results assume the relative contact frequencies in schools and the community are fixed at ρS = 3 and ρC = 1. A sensitivity analysis for R0 with respect to ρS and ρC is shown in Figure 2, where three levels chosen from previous work [22] are considered for each parameter. These estimates are not sensitive to ρS, but are sensitive to ρC, which is likely due to the fact that ρS  is only associated with children and children are the least exposed to the environmental reservoir as compared with other age groups. Under long incubation and infectious periods and α = 0.1, ρC = 1.5 could yield estimates as high as 0.15 for R0. On the other hand, under short incubation and infectious periods, α = 1, and ρC = 0.5, the estimate for R0 could be as low as 0.05. Overall, R0  is well below one, so that sustained person-to-person transmission will not take place.

Figure 2. Stratified estimates of basic reproductive number based on household clusters of avian influenza A(H7N9) cases in humans, China, February–May 2013 (113 households, 118 cases) and October 2013–March 2014 (181 households, 190 cases) 

With limited data about secondary transmission, we examine whether the household transmissibility of the virus changed between the two waves. In addition, possible heterogeneity in the risk of infection from a human source between the sexes and between age groups (adults (18 years or older) versus children (under 18 years)) are tested using the logistic regression in the chain binomial model. The results are summarised in Table 3, suggesting that the estimated odds ratios of within-household secondary transmission are relatively robust to assumptions about the natural history of the disease and the relative contact frequency in the hospital versus in the household. None of these factors have a significant effect on secondary transmission, possibly due to the lack of a sufficient number of secondary transmissions. However, males appeared to have a somewhat higher risk of infection from a human source compared with females, the odds ratio being 2.24 (95% CI: 0.69 to 7.26), though not statistically significant, under a medium length of incubation and infectious periods and α = 1. There was no significant difference in the risk between adults and children, the odds ratio being 0.66 (95% CI: 0.20 to 2.19). The odds ratio between the second and the first waves was 1.3 (95% CI: 0.4 to 4.27), suggesting the virus did not gain much human-to-human transmissibility between the two waves.

Table 3. Estimates of odds ratios of within-household secondary transmission with regard to the wave indicator (second wave to first wave), sex (men to women) and age group (adults to children)a based on household clusters of avian influenza A(H7N9) cases in humans, China, February–May 2013 (113 households, 118 cases) and October 2013–March 2014 (181 households, 190 cases)

Two of the families in the second wave may have had multiple index cases, since symptom onsets in the first and second cases were only two days apart, and both cases were believed to have had exposure to live poultry. A sensitivity analysis was performed assuming the first two cases in each of these two families were both index cases. This assumption of multiple index cases removes the short serial intervals, leading to a longer mean serial interval of 8.4 days (95% CI: 6.8 to 9.6). In the setting of medium-length incubation and infectious periods and α=1, estimates for the SAR and R0 are slightly lowered, to 1.2% (95% CI: 0.68 to 2.1) and 0.067 (95% CI: 0.038 to 0.12), respectively. The differences in transmissibility between waves and in the risk of infection between adults and children further diminish with the odds ratios, to 1.0 (95% CI: 0.29 to 3.48) and 0.93 (95% CI: 0.25 to 3.51), respectively.

Thus far, we have assumed b = 0 , i.e. all secondary cases were infected by the index cases. To assess how sensitive the estimates of SAR and R0 are to the value of b and to allow for the possibility of imported cases during each household outbreak, another set of analyses were conducted with b = 9.67 × 10−5, the only non-zero MLE obtained when both the incubation and infectious periods are short. As expected, the estimates of both the SAR and R0 are slightly lowered (Table 4). The ranges of the point estimates are 1.1–2.0% for the SAR and 0.06–0.11 for R0, compared with 1.3–2.2% and 0.07–0.12, respectively, when b = 0. Large values for b would further reduce the estimates of SAR and R0 but may not be reasonable assumptions as b is generally much smaller than p and the estimates of p in our analyses are at the 10−3 scale.

Table 4. Estimates of secondary attack rate and basic reproductive number based on household clusters of avian H7N9 cases in humans, taking into account the probability of infection by external sources, China, February–May 2013 (113 households, 118 cases) and October 2013–March 2014 (181 households, 190 cases)


We found statistical evidence of human-to-human transmission of the avian influenza A (H7N9) virus, but it is clear that such transmission is not sustainable. Our estimate of the household SAR is below 2%, and the estimate of R0 = 0.08 is way below the threshold 1. In contrast, for seasonal human influenza, the estimates for the household SAR mostly range from 10% to 30% [22], and the R0 estimates vary from 1.1 to 1.6 [31]. For past pandemic influenza strains, R0  estimates are somewhat higher, e.g. from 1.3 to 1.7 for A(H1N1)pdm09, 1.5 to 1.8 for H2N2 and H3N2 in the late 1950s and 60s, and 1.8 to 2.4 for H1N1 in 1918 [22,32]. Our R0  estimate for H7N9 is similar to a previous estimate of 0.10 [19]. However, our estimate is based on comprehensive household data covering two epidemic waves and partially accounts for heterogeneity in clustering pattern across age groups, whereas the previous estimate was made using only data from the first wave under the simplified but unrealistic assumption of random mixing of the whole population. Our estimate is relatively robust to uncertainty in the natural history of the disease but is somewhat sensitive to the relative transmission intensity in the community at large. Obtained via a Bayesian approach, the previous estimate had a credible interval of 0.01 to 0.49, much wider than our CIs, even with the uncertainty in ρC and ρS factored in, and was sensitive to the prior distribution of R0. In addition, we provide the first estimate for the household SAR, which could be useful in future simulation studies involving household transmission.

In the resampling-based testing of p = 0, we implicitly assume that b is constant over time. This assumption is unlikely to be true, as the exposure to zoonotic infection was substantially reduced when live poultry markets were closed in heavily affected areas from mid-April to June in 2013 and from late January to February in 2014 to control the spread [33]. Due to the difficulty of the resampling-based test in handling covariates, we used an asymptotic test [34] to address this issue. The effect of market closure on b has to be assumed known to implement this test, and we explored three values for the odds ratio (1.0, 0.5 and 0.1) for market closure versus without closure. The value of 0.1, or 90% reduction, is close to previous estimates [33]. The p values are all less than 0.001, consistent with the statistical significance of human-to-human transmission. However, the significance level should not be over-interpreted, as the asymptotic test may not be suitable for sparse data [29].

We did not find statistical evidence for sex or age differences in the risk of human-to-human transmission, which could be due to the lack of power to detect such differences. Higher risk of poultry-to-human transmission in males was previously noticed during the first wave [6] and was also reflected in the male-to-female ratio of index case numbers in our household data: 88/37 during the first wave and 124/65 during the second. One hypothesis for such a difference between the sexes is that in the Yangtze River Delta, in particular Shanghai, where the first wave originated from, old men more frequently visit live poultry markets than women. In our analysis, male household contacts appeared to have a somewhat higher risk of infection than female contacts. If this sex difference was true, it might imply that the majority of non-index cases were infected by zoonotic rather than human sources. On the other hand, if there were truly no age difference, it implies that most non-index household cases were infected by human sources, or otherwise more adult non-index cases would have been observed in households, because adults were believed to be more prone to infection by poultry due to increased exposure [6,30]. The lack of age difference in human-to-human transmission is also consistent with the fact that most people were naive to this novel virus [35]. More household data in future outbreaks should be collected to re-examine the sex and age effects on the human-to-human transmissibility of the virus.

Our analysis could be improved if we had genetic sequences and/or exposure and contact tracing information to help narrow the source of infection. Genetic linkage has been established in a couple of households included in our data [15-17]. However, similar viral genetic sequences do not necessarily imply human-to-human transmission, as the same virus could have been contracted from the same animal source. On the other hand, a certain level of heterogeneity in genetic sequences would imply impossible direct transmission pairs. Exposure and contact tracing information was obtained for some but not all cases in our study, but such data lack details and are subject to recall bias. Moreover, simultaneous testing of both human cases and possible animal sources would be helpful, but it is often difficult to trace the animal source, e.g. poultry purchased as food, or to coordinate between administrative units in charge of human health and those responsible for animal surveillance.

The human-to-human transmissibility of H7N9 remained not only limited but also temporally stable. We observed only a minor increase in the SAR estimates between the two successive waves, which is likely just a stochastic effect. However, some recent studies suggested genetic changes in the RNA segments of NS, NP and PB of the viral samples in Guangdong Province of southern China during the second wave as compared with sequences in eastern and central China from the first wave [36]. In addition, these segments are similar to the influenza A(H9N2) viruses circulating in the same province, giving rise to concern about reassortment of H7N9 with viruses that could lead to more efficient human-to-human transmission. Therefore, the efforts on collecting and analysing household transmission data should be continued in addition to the routine surveillance and contact tracing. Should human H7N9 transmissibility increase to the level of that of seasonal human influenza, it would be very important to deploy antivirals agents and vaccines in areas where human cases are occurring. Human H7N9-inactivated vaccines are being developed by government agencies and private pharmaceutical companies [37]. These vaccines are currently in phase I and II safety and immunogenicity trials. The use of antiviral agents and vaccines needs to be incorporated into a comprehensive programme for the assessment of transmissibility and intervention effectiveness.

YY, EK, DC, IL and MH were partially supported by the National Institute of General Medical Sciences MIDAS grant U54-GM111274; YY, IL and MH were also partially supported by the National Institute of Allergy and Infectious Diseases (NIAID) grant R37-AI032042. EK was also supported by NIAID grant K99/R00 AI095302. ZF and WC were partially supported by the Ministry of Science and Technology of China grant KJYJ-2013-01-02.

Conflict of interest
None declared.

Authors’ contributions
Yang Yang, Ira Longini, Zijian Feng and Wuchun Chao conceived the study and evaluated study results. Yang Yang, Liqun Fang, and Ira Longini designed analysis plan. Zijian Feng, Yanping Zhang, Enfu Chen, Jiayu Hu and Fenyang Tang collected data. Liqun Fang and Maijuan Ma provided further data support and verification. Yang Yang conducted data analysis. M. Elizabeth Halloran, Song Liang, Tom Britton and Eben Kenah evaluated study results. Yang Yang drafted the manuscript. Yang Yang, Ira Longini, Elizabeth Halloran, Zijian Feng, Wuchun Chao and Song Liang contributed to the final version. Ira Longini, Zijian Feng and Wuchun Cao share equal senior responsibility.

  1. Lam TTY, Wang J, Shen Y, Zhou B, Duan L, Cheung C-L, et al. The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature. 2013;502(7470):241-4. PMID:23965623
  2. Liu D, Shi W, Shi Y, Wang D, Xiao H, Li W, et al. Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses. Lancet. 2013;381(9881):1926-32. PMID:23643111
  3. Xiong X, Martin SR, Haire LF, Wharton SA, Daniels RS, Bennett MS, et al. Receptor binding by an H7N9 influenza virus from humans. Nature. 2013;499(7459):496-9. PMID:23787694
  4. Belser JA, Gustin KM, Pearce MB, Maines TR, Zeng H, Pappas C, et al. Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice. Nature. 2013;501(7468):556-9. PMID:23842497
  5. Richard M, Schrauwen EJA, de Graaf M, Bestebroer TM, Spronken MIJ, van Boheemen S, et al. Limited airborne transmission of H7N9 influenza A virus between ferrets. Nature. 2013;501(7468):560-3. PMID:23925116
  6. Cowling BJ, Jin L, Lau EHY, Liao Q, Wu P, Jiang H, et al. Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet. 2013;382(9887):129-37. PMID:23803488
  7. Yu H, Cowling BJ, Feng L, Lau EHY, Liao Q, Tsang TK, et al. Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. Lancet. 2013;382(9887):138-45. PMID:23803487
  8. Gao HN, Lu HZ, Cao B, Du B, Shang H, Gan JH, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med. 2013;368(24):2277-85. PMID:23697469
  9. Dudley JP, Mackay IM. Age-specific and sex-specific morbidity and mortality from avian influenza A(H7N9). J Clin Virol. 2013;58(3):568-70. PMID:24091087
  10. Hope-Simpson RE. The role of season in the epidemiology of influenza. J Hyg (Lond). 1981;86(1):35-47. PMID:7462597
  11. Hampson AW. Epidemiological data on influenza in Asian countries. Vaccine. 1999;17(Suppl 1):S19-23. PMID:10471175
  12. Chen E, Chen Y, Fu L, Chen Z, Gong Z, Mao H, et al. Human infection with avian influenza A(H7N9) virus re-emerges in China in winter 2013. Euro Surveill. 2013;18(43):20616. PMID:24176616
  13. Sutton TC, Finch C, Shao H, Angel M, Chen H, Capua I, et al. Airborne transmission of highly pathogenic H7N1 influenza virus in ferrets. J Virol. 2014;88(12):6623-35. PMID:24696487
  14. Halloran ME, Ferguson NM, Eubank S, Longini IM Jr, Cummings DA, Lewis B, et al. Modeling targeted layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci USA. 2008;105(12):4639-44. PMID:1833243
  15. Qi X, Qian YH, Bao CJ, Guo XL, Cui LB, Tang FY, et al. Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation. BMJ. 2013;347:f4752. PMID:23920350
  16. Hu J, Zhu Y, Zhao B, Li J, Liu L, Gu K, et al. Limited human-to-human transmission of avian influenza A(H7N9) virus, Shanghai, China, March to April 2013. Euro Surveill. 2014;19(25):20838. PMID:24993556
  17. Xiao XC, Li KB, Chen ZQ, Di B, Yang ZC, Yuan J, et al. Transmission of avian influenza A(H7N9) virus from father to child: a report of limited person-to-person transmission, Guangzhou, China, January 2014. Euro Surveill. 2014;19(25). pii: 20837. PMID:24993555
  18. Li Q, Zhou L, Zhou M, Chen Z, Li F, Wu H, et al. Epidemiology of human infections with avian influenza A(H7N9) virus in China. N Engl J Med. 2014;370(6):520-32. PMID:23614499
  19. Chowell G, Simonsen L, Towers S, Miller MA, Viboud C. Transmission potential of influenza A/H7N9, February to May 2013, China. BMC Med. 2013;11(1):214. PMID:24083506
  20. Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J, et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet. 2013;381(9881):1916-25. PMID:23623390
  21. Huang Y, Xu K, Ren DF, Ai J, Ji H, Ge AH, et al. Probably longer incubation period for human infection with avian influenza A (H7N9) virus in Jiangsu province, China, 2013. Epidemiol Infect. 2014;142(12):2647-53.
  22. Yang Y, Sugimoto JD, Halloran ME, Basta NE, Chao DL, Matrajt L, et al. The transmissibility and control of pandemic influenza A (H1N1) virus. Science. 2009;326(5953):729-33. PMID:19745114
  23. Clinical signs and symptoms of influenza.; last accessed on 8/15/2014.</eref>
  24. <jrn>24. Murphy BR, Rennels MB, Douglas RG Jr, Betts RF, Couch RB, Cate TR Jr, et al. Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers. Infect Immun. 1980;29(2):348-55. PMID:7216417
  25. To KK, Chan KH, Li IW, Tsang TY, Tse H, Chan JF, et al. Viral load in patients infected with pandemic H1N1 2009 influenza A virus. J Med Virol. 2010;82(1):1-7. PMID:19950247
  26. Li IW, Hung IF, To KK, Chan KH, Wong SS, Chan JF, et al. The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment. Chest. 2010;137(4):759-68. PMID:20061398
  27. Mok CKP, Lee HHY, Chan MCW, Sia SF, Lestra M, Nicholls JM, et al. Pathogenicity of the novel A/H7N9 influenza virus in mice. MBio. 2013;4(4). pii: e00362-13. PMID:23820393
  28. Yang Y, Longini IM Jr, Halloran ME. Design and evaluation of prophylactic interventions using infectious disease incidence data from close contact groups. J R Stat Soc Ser C Appl Stat. 2006;55(3):317-30. PMID:22457545
  29. Yang Y, Longini IM, Halloran ME. A resampling-based test to detect person-to-person transmission of infectious disease. Ann Appl Stat. 2007;1(1):211-28. PMID:19436773
  30. Liao Q, Lam WT, Leung GM, Jiang C, Fielding R. Live poultry exposure, Guangzhou, China, 2006. Epidemics. 2009;1(4):207-12. PMID:21352767
  31. Basta NE, Halloran ME, Matrajt L, Longini IM Jr. Estimating influenza vaccine efficacy from challenge and community-based study data. Am J Epidemiol. 2008;168(12):1343-52. PMID:18974084
  32. Mills CE, Robins JM, Lipsitch M. Transmissibility of 1918 pandemic influenza. Nature. 2004;432(7019):904-6. PMID:15602562
  33. Yu H, Wu JT, Cowling BJ, Liao Q, Fang VJ, Zhou S, et al. Effect of closure of live poultry markets on poultry-to-person transmission of avian influenza A H7N9 virus: an ecological study. Lancet. 2014;383(9916):541-8. PMID:24183056
  34. Self SG, Liang KY. Asymptotic properties of maximum likelihood estimators and likelihood ratio tests under nonstandard conditions. J Am Stat Assoc. 1987;82(398):605-10.
  35. Bai T, Zhou J, Shu Y. Serologic study for influenza A (H7N9) among high-risk groups in China. N Engl J Med. 2013;368(24):2339-40. PMID:23718151
  36. Lu J, Wu J, Guan D, Yi L, Zeng X, Zou L, et al. Genetic changes of reemerged influenza A(H7N9) viruses, China. Emerg Infect Dis. 2014;20(9):1582-3. PMID:25153821
  37. National Institutes of Health (NIH). NIH begins testing H7N9 avian influenza vaccine candidate. Bethesda, MD; 18 Sep 2013. [Accessed 31 Dec 2014]. Available from:

Back to Table of Contents
Previous Download (pdf)

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.